190 related articles for article (PubMed ID: 10030690)
1. Estrogenic and antiestrogenic activities of 16alpha- and 2-hydroxy metabolites of 17beta-estradiol in MCF-7 and T47D human breast cancer cells.
Gupta M; McDougal A; Safe S
J Steroid Biochem Mol Biol; 1998 Dec; 67(5-6):413-9. PubMed ID: 10030690
[TBL] [Abstract][Full Text] [Related]
2. Involvement of genotoxic effects in the initiation of estrogen-induced cellular transformation: studies using Syrian hamster embryo cells treated with 17beta-estradiol and eight of its metabolites.
Tsutsui T; Tamura Y; Yagi E; Barrett JC
Int J Cancer; 2000 Apr; 86(1):8-14. PubMed ID: 10728588
[TBL] [Abstract][Full Text] [Related]
3. 17 beta-estradiol- and 4-hydroxytamoxifen-induced transactivation in breast, endometrial and liver cancer cells is dependent on ER-subtype, cell and promoter context.
Castro-Rivera E; Safe S
J Steroid Biochem Mol Biol; 2003 Jan; 84(1):23-31. PubMed ID: 12648521
[TBL] [Abstract][Full Text] [Related]
4. Comparison of possible carcinogenic estradiol metabolites: effects on proliferation, apoptosis and metastasis of human breast cancer cells.
Seeger H; Wallwiener D; Kraemer E; Mueck AO
Maturitas; 2006 Apr; 54(1):72-7. PubMed ID: 16213115
[TBL] [Abstract][Full Text] [Related]
5. Direct action of naturally occurring estrogen metabolites on human osteoblastic cells.
Robinson JA; Waters KM; Turner RT; Spelsberg TC
J Bone Miner Res; 2000 Mar; 15(3):499-506. PubMed ID: 10750564
[TBL] [Abstract][Full Text] [Related]
6. Mitogenic estrogen metabolites alter the expression of 17beta-estradiol-regulated proteins including heat shock proteins in human MCF-7 breast cancer cells.
Kim SH; Lee SU; Kim MH; Kim BT; Min YK
Mol Cells; 2005 Dec; 20(3):378-84. PubMed ID: 16404153
[TBL] [Abstract][Full Text] [Related]
7. Differential effects of 16alpha-hydroxyestrone and 2-methoxyestradiol on cyclin D1 involving the transcription factor ATF-2 in MCF-7 breast cancer cells.
Lewis JS; Thomas TJ; Pestell RG; Albanese C; Gallo MA; Thomas T
J Mol Endocrinol; 2005 Feb; 34(1):91-105. PubMed ID: 15691880
[TBL] [Abstract][Full Text] [Related]
8. 3,3'4,4'-Tetrachlorobiphenyl exhibits antiestrogenic and antitumorigenic activity in the rodent uterus and mammary cells and in human breast cancer cells.
Ramamoorthy K; Gupta MS; Sun G; McDougal A; Safe SH
Carcinogenesis; 1999 Jan; 20(1):115-23. PubMed ID: 9934858
[TBL] [Abstract][Full Text] [Related]
9. Estrogen and aryl hydrocarbon responsiveness of ECC-1 endometrial cancer cells.
Castro-Rivera E; Wormke M; Safe S
Mol Cell Endocrinol; 1999 Apr; 150(1-2):11-21. PubMed ID: 10411295
[TBL] [Abstract][Full Text] [Related]
10. Catecholestrogen regulation of prolactin synthesis in pituitary cell culture.
Shupnik MA; Klibanski A; Longcope C; Ridgway EC
Endocrinology; 1985 Sep; 117(3):939-46. PubMed ID: 4017968
[TBL] [Abstract][Full Text] [Related]
11. Estrogenic activity of a dieldrin/toxaphene mixture in the mouse uterus, MCF-7 human breast cancer cells, and yeast-based estrogen receptor assays: no apparent synergism.
Ramamoorthy K; Wang F; Chen IC; Norris JD; McDonnell DP; Leonard LS; Gaido KW; Bocchinfuso WP; Korach KS; Safe S
Endocrinology; 1997 Apr; 138(4):1520-7. PubMed ID: 9075711
[TBL] [Abstract][Full Text] [Related]
12. A pilot study of urinary estrogen metabolites (16alpha-OHE1 and 2-OHE1) in postmenopausal women with and without breast cancer.
Ursin G; London S; Stanczyk FZ; Gentzschein E; Paganini-Hill A; Ross RK; Pike MC
Environ Health Perspect; 1997 Apr; 105 Suppl 3(Suppl 3):601-5. PubMed ID: 9168002
[TBL] [Abstract][Full Text] [Related]
13. The role of 17β-estradiol metabolites in chromium-induced oxidative stress.
Sawicka E; Długosz A
Adv Clin Exp Med; 2017; 26(2):215-221. PubMed ID: 28791837
[TBL] [Abstract][Full Text] [Related]
14. Lycium barbarum inhibits growth of estrogen receptor positive human breast cancer cells by favorably altering estradiol metabolism.
Li G; Sepkovic DW; Bradlow HL; Telang NT; Wong GY
Nutr Cancer; 2009; 61(3):408-14. PubMed ID: 19373615
[TBL] [Abstract][Full Text] [Related]
15. Formation of depurinating N3Adenine and N7Guanine adducts by MCF-10F cells cultured in the presence of 4-hydroxyestradiol.
Saeed M; Rogan E; Fernandez SV; Sheriff F; Russo J; Cavalieri E
Int J Cancer; 2007 Apr; 120(8):1821-4. PubMed ID: 17230531
[TBL] [Abstract][Full Text] [Related]
16. Radioimmunoassay and metabolic clearance rate of catecholestrogens, 2-hydroxyestrone and 2-hydroxyestradiol in man.
Kono S; Merriam GR; Brandon DD; Loriaux DL; Lipsett MB; Fujino T
J Steroid Biochem; 1983 Jul; 19(1B):627-33. PubMed ID: 6310246
[TBL] [Abstract][Full Text] [Related]
17. Urinary 2-hydroxyestrone/16alpha-hydroxyestrone ratio and family history of breast cancer in premenopausal women.
Ursin G; London S; Yang D; Tseng CC; Pike MC; Bernstein L; Stanczyk FZ; Gentzschein E
Breast Cancer Res Treat; 2002 Mar; 72(2):139-43. PubMed ID: 12038704
[TBL] [Abstract][Full Text] [Related]
18. 16alpha-hydroxyestrone inhibits estrogen sulfotransferase activity in human liver cancer cells.
Campisi I; Granata OM; Cocciadiferro L; Calabrò M; Polito LM; Carruba G
Ann N Y Acad Sci; 2009 Feb; 1155():237-41. PubMed ID: 19250210
[TBL] [Abstract][Full Text] [Related]
19. Estradiol metabolites are potent mitogenic substances for human ovarian cancer cells.
Seeger H; Wallwiener D; Kraemer E; Mueck AO
Eur J Gynaecol Oncol; 2005; 26(4):383-5. PubMed ID: 16122183
[TBL] [Abstract][Full Text] [Related]
20. Estradiol and its metabolites 4-hydroxyestradiol and 2-hydroxyestradiol induce mutations in human breast epithelial cells.
Fernandez SV; Russo IH; Russo J
Int J Cancer; 2006 Apr; 118(8):1862-8. PubMed ID: 16287077
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
